XML 56 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 8 - Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2014
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

Weighted

Average,

December 31,

2014

   

Range,

December 31,

2014

   

Weighted

Average,

December 31,

2013

   

Range,

December 31,

2013

 

Volatility

    80%       80%       49%        49%-50%  

Dividend yield

    -       -       -       -  

Risk-free interest rate

    0.51%       0.51%       0.62%       0.59%-0.68%  

Expected term (years)

    2       2       2.68       2.63-2.71  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   

Options

   

Weighted-

Average

Exercise

Price

   

Weighted-

Average

Remaining

Contractual

Life

   

Aggregate

Intrinsic

Value

 

Outstanding at July 1, 2014

    4,258,870       2.81       3.2       -  

Granted

    50,000       1.00                  

Exercised

    -       -                  

Forfeited

    -       -                  

Expired

    (397,500 )     3.06                  

Outstanding at December 31, 2014

    3,911,370     $ 2.76       3.1     $ -  

Exercisable at December 31, 2014

    3,911,370     $ 2.76       3.1     $ -  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   

Three

months

ended

December 31,

2014

   

Three

months

ended

December 31,

2013

   

Six months

ended

December 31,

2014

   

Six months

ended

December 31,

2013

 

General and administrative:

                               

Fair value of stock issued to an employee

  $ -       24,999     $ -       94,998  

Change in fair value from modification of option terms

    11,783       -       11,783       307,638  

Fair value of stock options expensed/(credited)

    4,000       (155,728 )     4,000       (87,517 )

Total

  $ 15,783     $ (130,729 )   $ 15,783     $ 315,119  
                                 

Research and development:

                               

Fair value of stock options credited

  $ -     $ (153,587 )   $ -     $ (135,939 )

Total

  $ -     $ (153,587 )   $ -     $ (135,939 )